Concepedia

Publication | Open Access

Effect of Fenofibrate on Progression of Diabetic Retinopathy

DOIFull Paper Access

63

Citations

14

References

2024

Year

David Preiss, Jennifer Logue, Emily Sammons, Mohammed Zayed, Jonathan Emberson, Rachel Wade, Karl Wallendszus, Will Stevens, Rosanna Cretney, Simon Harding,
NEJM Evidence

Abstract

Fenofibrate reduced progression of diabetic retinopathy compared with placebo among participants with early retinal changes. (Funded by the National Institute for Health and Care Research; ClinicalTrials.gov number, NCT03439345; ISRCTN number, ISRCTN15073006.).

References

YearCitations

Page 1